Daniel Yazbeck

CEO & Founder, MyDx, Inc.

Daniel Yazbeck

CEO & Founder, MyDx, Inc.
linkedin-icon twitter-icon facebook-icon


Daniel Yazbeck is on a mission to help people Trust & Verify what they put into their minds and bodies. He founded the Yazbeck Consulting & Investment Group in 2007, which later became the seed investor in CDx, Inc – the makers of MyDx, the world’s first handheld chemical analyzer that will empower end consumers to test the safety and potency of everything they eat, drink and inhale. Daniel comes with over 13 years of experience helping some of the top Fortune 500 companies grow, including Pfizer Pharmaceuticals as a Scientist specializing in Chemical R&D Technologies as well as Panasonic, spearheading their new Market, Business and Strategic Product Development activities in the consumer electronics healthcare field. Daniel holds a Master’s Degree in Medicinal Chemistry from McGill University, with a minor in Marketing, and is an inventor and author on several world patents and research publications. To learn more, please visit www.yazbeckinvestments.comClick here to see an investor presentation from MyDX, Inc.

Upcoming Speaking Engagements:

The Cannabis Growth Capital Conference: November 10th & 11th, 2015

The New West Summit: November 20-21, 2015

The Emerald Conference: January 21st-22nd, 2016


Past Speaking Engagements:

CDx CEO Daniel Yazbeck Featured Panelist at Marijuana Investor, Technology and Healthcare Events

National Cannabis Summit 2015 – Consumer Technology in the Cannabis Sector

Feature Articles:

MyDx’s Users Can Transform an Anecdotal Industry into Scientific Cannabis Data

MyDX Looks to Crack Open the Green Leaf